🧪
hypothesis

PINK1/Parkin–TREM2 Axis: Convergent Mitophagy Failure Unifies PD (SNCA/αSyn) and AD (tau/Abeta) Pathology

Hypothesis

PINK1/Parkin–TREM2 Axis: Convergent Mitophagy Failure Unifies PD (SNCA/αSyn) and AD (tau/Abeta) Pathology

Convergence hypothesis: PINK1/Parkin-mediated mitophagy dysfunction in neurons and TREM2-mediated microglial mitophagy failure represent a unified convergence point driving both Parkinson's disease (PD) and Alzheimer's disease (AD) patho.
🧬 PINK1,PRKN,TREM2,STUB1,NDUFS7🩺 neurodegeneration🎯 Composite 78%💱 $0.52▼3.9%proposed
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 2 oppose
⚠ Orphaned Senate Quality Gates →
🏆 ChallengeSolve: PINK1/Parkin–TREM2 Axis: Convergent Mitophagy Failure Unifies PD (SNCA/αS$128K →
☰ Compare⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite78%

🧪 Overview

Convergence hypothesis: PINK1/Parkin-mediated mitophagy dysfunction in neurons and TREM2-mediated microglial mitophagy failure represent a unified convergence point driving both Parkinson's disease (PD) and Alzheimer's disease (AD) pathophysiology.

PD-specific mechanism: PINK1 kinase phosphorylates Parkin (PRKN) and ubiquitin at mitochondrial outer membrane, triggering clearance of damaged mitochondria. In PD, mutations in PINK1 (PARK6) or PRKN (PARK2) impair this clearance, leading to mitochondrial ROS spillover that accelerates α-synuclein aggregation. The α-synuclein (SNCA) feedback loop then further inhibits mitochondrial complex I (NDUFS7), creating a vicious cycle.

AD-specific mechanism: TREM2 R47H/haploinsufficiency in AD reduces microglial mitophagic capacity, preventing clearance of mitochondrial debris from synapses. Accumulated mitochondrial damage elevates regional oxidative stress, which hyperphosphorylates tau (MAPT) via GSK3B activation and drives amyloid-beta (APP/ABCA1) aggregation. The tau feedback loop further suppresses complex I efficiency, creating a parallel vicious cycle.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Damaged Mitochondria<br/>ROS and Depolarization"]
    B["PINK1 Accumulation<br/>Outer Membrane Signal"]
    C["PRKN Parkin Recruitment<br/>Ubiquitin Phosphorylation"]
    D["Mitophagosome Formation<br/>STUB1 and Autophagy Adaptors"]
    E["TREM2 Microglial Mitophagy<br/>Innate Immune Energy Control"]
    F["Failed Mitochondrial Clearance<br/>Inflammatory ROS Loop"]
    G["PD SNCA and AD Tau Abeta Convergence<br/>Neurodegeneration"]
    A --> B
    B --> C
    C --> D
    E --> D
    D -.->|"when impaired"| F
    F --> G
    style C fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports0 contradicts
Supports
Spautin-1 promotes PINK1-PRKN-dependent mitophagy and improves associative learning capability in an alzheimer disease animal model.
Autophagy2024PMID:39051473medium
Supports
PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models.
Autophagy2023PMID:36282767medium
Supports
PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.
Acta Neuropathol Commun2020PMID:33168089medium
Supports
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease.
Nat Neurosci2019PMID:30742114medium
Supports
Targeting mitophagy in neurodegenerative diseases.
Nat Rev Drug Discov2025PMID:39809929medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — PINK1

🧬 PDB 6EQI Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for PINK1,PRKN,TREM2,STUB1,NDUFS7 →

No DepMap CRISPR Chronos data found for PINK1,PRKN,TREM2,STUB1,NDUFS7.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.1286
Events (7d)
1
Price History
▼3.9%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
iPSC-derived microglia from TREM2 R47H AD patients with PINK1/PRKN knockdown will show synergistic exacerbation of mitophagy failure, with intracellular Abeta42 increasing more than either interventio— no observation —open0.72
Post-mortem PD substantia nigra and AD prefrontal cortex both show reduced Parkin and TREM2 protein by >40% compared to age-matched controls.— no observation —open0.75
🔮 Falsifiable Predictions (2)
openconf —
iPSC-derived microglia from TREM2 R47H AD patients with PINK1/PRKN knockdown will show synergistic exacerbation of mitophagy failure, with intracellular Abeta42 increasing more than either intervention alone.
Falsification: iPSC-derived microglia from TREM2 R47H AD patients transduced with PINK1 or PRKN shRNA show >30% increase in Abeta42 ELISA vs. either knockdown alone after 14 days differentiation.
openconf —
Post-mortem PD substantia nigra and AD prefrontal cortex both show reduced Parkin and TREM2 protein by >40% compared to age-matched controls.
Falsification: Western blot quantification of Parkin (PRKN) and TREM2 in PD substantia nigra (n>=10) and AD prefrontal cortex (n>=10) vs. age-matched controls (n>=10 each) shows >40% reduction.
View on SciDEX ↗